Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1992-5-28
|
| pubmed:abstractText |
Stage IIIA non-small-cell lung carcinoma (NSCLC) is composed of regionally advanced yet potentially resectable disease. Many trials have evaluated a variety of therapeutic strategies. Most have been single-arm phase II trials, although a number of comparative phase III trials have also been performed. This review critically evaluates the existing literature on the treatment of stage IIIA NSCLC, particularly the various multimodality approaches that have been used.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0732-183X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
10
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
829-38
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:1314892-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:1314892-Chemotherapy, Adjuvant,
pubmed-meshheading:1314892-Combined Modality Therapy,
pubmed-meshheading:1314892-Drug Evaluation,
pubmed-meshheading:1314892-Humans,
pubmed-meshheading:1314892-Lung Neoplasms,
pubmed-meshheading:1314892-Neoplasm Staging,
pubmed-meshheading:1314892-Randomized Controlled Trials as Topic
|
| pubmed:year |
1992
|
| pubmed:articleTitle |
Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research.
|
| pubmed:affiliation |
Division of Hematology-Oncology and Thoracic Surgery, Brigham and Women's Hospital, Boston, MA 02115.
|
| pubmed:publicationType |
Journal Article,
Review
|